Ebrahimi, K.A. (2021) “Significance of KIT and PDGFRA mutations in gastric gastrointestinal stromal tumor imatinib-naive surgically treated patients”, Vojnosanitetski pregled, 76(12). doi:10.2298/VSP180205048E.